Recursion, targeting cancer, rare disease midstage tests, sets terms for $306M IPO

cafead

Administrator
Staff member
  • cafead   Apr 13, 2021 at 10:42: AM
via Recursion Pharmaceuticals has set terms for a major $306 million IPO as the artificial intelligence biotech eyes a $3 billion valuation.

article source
 

<